Scarica l'app Stockscreener
4.315
3.68%
-0.165
Dopo l'orario di chiusura:
4.23
-0.085
-1.97%
Precedente Chiudi:
$4.48
Aprire:
$4.37
Volume 24 ore:
12,432
Relative Volume:
0.30
Capitalizzazione di mercato:
$6.42M
Reddito:
$59.11M
Utile/perdita netta:
$-33.38M
Rapporto P/E:
-0.0241
EPS:
-178.995
Flusso di cassa netto:
$-26.04M
1 W Prestazione:
+0.33%
1M Prestazione:
+2.98%
6M Prestazione:
-17.81%
1 anno Prestazione:
-74.77%
Intervallo 1D:
$4.11
$4.525
Intervallo di 1 settimana:
$3.4791
$4.87
Portata 52W:
$2.5211
$38.52
Dna X Inc Stock (SONM) Company Profile
Nome
Dna X Inc
Settore
Industria
Telefono
650-378-8100
Indirizzo
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
4.315 | 6.67M | 59.11M | -33.38M | -26.04M | -179.00 |
MSFT
Microsoft Corp
|
416.03 | 3.11T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
193.06 | 552.43B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
136.60 | 328.14B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
671.55 | 168.87B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
534.56 | 100.52B | 8.00B | 1.10B | 2.28B | 6.4708 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-10-31 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-07-18 | Iniziato | B. Riley FBR | Buy |
| 2019-07-09 | Aggiornamento | National Securities | Neutral → Buy |
| 2019-06-10 | Iniziato | National Securities | Neutral |
| 2019-06-04 | Iniziato | Lake Street | Buy |
| 2019-06-04 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Dna X Inc Borsa (SONM) Ultime notizie
DNA X Inc. (SONM) Q3 2024 Earnings: EPS Beats Estimates, Stock Surges 13.71%Community Hot Stocks - Newser
DNA X Inc. (SONM) Surges 13% as Buyer Demand Tests Key Resistance at $4.68Institutional Grade Picks - Newser
Ginkgo Bioworks Holdings Inc (DNA): What’s the Future of Autonomous Lab? - Yahoo Finance Singapore
12 Information Technology Stocks Moving In Thursday's Intraday SessionAmplitech Group, Inc.Series A - Benzinga
DNA X, Inc. (SONM) Reports Q1 2026 Financial Results, Completes Mobile Business Sale, and Focuses on AI Crypto Trading Platform - Minichart
DNA X, Inc. Reports First Quarter 2026 Financial Results - Scott Coop
DNA X: Q1 Earnings Snapshot - kare11.com
DNA X, Inc. 1Q 2026: Revenue $0 Net income $6.34M, EPS $5.01— 10-Q Summary - TradingView
SONM: Q1 2026 net income surged to $6.3M on asset sale, but core crypto trading posted a $3.9M loss - TradingView
DNA X, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
DNA X (NASDAQ: SONM) exits handset business, leans on crypto platform and new funding - Stock Titan
SONM: Exited legacy business, posted strong net income, and pivoted to AI crypto trading platform - TradingView
DNA X (NASDAQ: SONM) exits phones, pivots to AI crypto trading - Stock Titan
FMAC Price Today: Future Money Acquisition Corporation Stock Price, Quote & Chart | MEXC - MEXC Exchange
AUC Price Today: ATIF Holdings Limited Stock Price, Quote & Chart | MEXC - MEXC
Stock Market News for May 20, 2026 - Stock Titan
Why Is DNA Brands, Inc. (DNAX) Stock Down Today? - Meyka
SONM Stock Price, Quote & Chart | DNA X INC (NASDAQ:SONM) - ChartMill
DNA X, Inc. Delays Quarterly Filing After Asset Sale - TipRanks
12 Information Technology Stocks Moving In Friday's After-Market Session - Benzinga
DNA X (SONM) delays Q1 2026 10-Q after Legacy Business sale; expects $3.6M loss - Stock Titan
Dna Brands Inc (OP: DNAX - The Chronicle-Journal
DNA X (SONM): Laurence Lytton discloses 120,357 shares (8.1%) - Stock Titan
How DNA's Double Helix Structure Was Discovered - Britannica
Takara Bio Inc stock (JP3463000004): Featured in expanding DNA polymerase and cell culture media mar - AD HOC NEWS
Lotus unveils Focus 2030 strategy with new hybrid-V8 supercar and X-Hybrid tech for global growth. - Pluang
Lotus Unveils Focus 2030Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar - The Manila Times
Lotus Unveils Focus 2030 – Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar - mykxlg.com
About Us | Oil & Gas JournalLotus Unveils Focus 2030 – Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar - FinancialContent
DNA X Inc. (SONM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price, News, Quote & History - Yahoo Finance
[8-K] Ginkgo Bioworks Holdings, Inc. Reports Material Event - Stock Titan
Central Bancompany, Inc. Announces Dividend Declaration and Reports May 2026 SEC Filing Results - Minichart
What DNA X (SONM) subscription metrics reveal about retention | Q3 2024: Profit Exceeds ViewsBuy Rating - newser.com
SONM | DNA X, Inc. Common Insider Trading - Quiver Quantitative
SONM Forecast, Price Target & Analyst Ratings | DNA X INC (NASDAQ:SONM) - ChartMill
[10-K/A] DNA X, Inc. Amends Annual Report - Stock Titan
[8-K] DNA X, Inc. Reports Material Event - Stock Titan
Ginkgo Bioworks will take investor questions after May 7 results - Stock Titan
Ansa Biotechnologies to Showcase Breakthrough DNA Synthesis Technology Backed by Industry’s Only On-Time Guarantee at SynBioBeta 2026 Conference - 01net
Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine - Business Wire
SONM Price Today: DNA X, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
SONM (DNA X) reports narrower than projected Q3 2024 loss, with shares rising 7.75 percent in today’s session.Viral Momentum Stocks - newser.com
INSP (Inspire Medical Systems Inc.) Q4 2025 EPS beats estimates by wide margin even as shares dip slightly today. - Cổng thông tin điện tử tỉnh Lào Cai
SONM (DNA X) tops Q3 2024 EPS forecasts, lifting shares nearly 10 percent on positive investor sentiment.Management Guidance - Cổng thông tin điện tử tỉnh Lào Cai
SONM SEC FilingsDNA X 10-K, 10-Q, 8-K Forms - Stock Titan
Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company - 富途牛牛
DNA X, Inc. Reports 2025 Financial Results, Completes Asset Sale, and Focuses on Growth of Cryptocurrency Trading Platform - Minichart
12 Information Technology Stocks Moving In Wednesday's After-Market Session - Benzinga
DNA X, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
DNA X (NASDAQ: SONM) outlines crypto shift, tiny scale and going‑concern risk - Stock Titan
Dna X Inc Azioni (SONM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Dna X Inc Azioni (SONM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| LYTTON LAURENCE W | 10% Owner |
Jun 30 '25 |
Sale |
1.39 |
400,514 |
556,714 |
0 |
1.60%
3.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):